INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹97 Cr | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr |
What is the latest Total Liabilities ratio of INDO US BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹97 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹43 Cr |
How is Total Liabilities of INDO US BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹97 Cr | 15.93 | |
| Mar2024 | ₹84 Cr | 21.65 | |
| Mar2023 | ₹69 Cr | 24.88 | |
| Mar2022 | ₹55 Cr | 27.04 | |
| Mar2021 | ₹43 Cr | - | |
Compare Total Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹197.0 Cr | -2.4% | -6.7% | -44.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,417.1 Cr | -0.9% | -12.2% | -42.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,983.9 Cr | -3.4% | -11% | -11.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,054.9 Cr | -3.9% | 1.9% | 6.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹975.9 Cr | -3.9% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹501.3 Cr | 1.2% | 11% | 9.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.4% |
-6.7% |
-44.6% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses